XPEL, Inc. Form 8-K Summary
Business Context and Reporting Period
XPEL, Inc. filed this Current Report on May 21, 2021, regarding new and terminated financing arrangements. The filing does not report operating results for a quarterly or annual reporting period.
Financing, Liquidity, and Key Terms
- XPEL entered into a loan agreement with Texas Partners Bank providing a $57 million revolving line of credit.
- Borrowings bear interest at the Wall Street Journal U.S. Prime Rate less 0.75% when the debt-to-EBITDA ratio is 2.00:1.00 or lower, or less 0.25% when the ratio exceeds 2.00:1.00.
- The facility carries a 0.25% fee on unused capacity, is secured by substantially all consolidated assets, and matures on July 5, 2024. Interest payments begin monthly on July 5, 2021.
- XPEL must maintain senior funded debt to EBITDA of no more than 3.50:1.00 and a minimum debt service coverage ratio of 1.25:1.00, tested quarterly on a rolling four-quarter basis.
- On May 21, 2021, XPEL repaid the outstanding $4,242,782 balance of a prior $6 million term loan using cash on hand and terminated that loan.
- The filing does not provide revenue, net income, cash flow, margin, borrowing availability, or the amount drawn under the new revolving facility.
Material Changes Versus the Prior Comparable Period
- XPEL replaced its prior term-loan obligation with a larger revolving credit facility and repaid the prior loan in full.
- The new facility increased potential borrowing capacity but also introduced collateral requirements and financial covenants.
Guidance, Outlook, Risks, and Unusual Items
- No earnings guidance, operating outlook, or management forecast is provided.
- Key risks include variable interest rates, the requirement to satisfy leverage and debt-service covenants, and the pledge of substantially all consolidated assets as collateral.
- Failure to comply with customary affirmative covenants or financial covenants could affect access to the facility and create potential default consequences; the filing does not specify those consequences.
- The agreement permits specified add-backs in calculating EBITDA, including limited equity-related, financing-related, acquisition-related, non-cash, and stock-based compensation expenses.
- The detailed terms are contained in Exhibit 10.1, the Loan Agreement dated May 21, 2021.
Important Facts for Investors to Verify
- Verify the amount, if any, drawn on the $57 million revolving facility and the remaining unused capacity.
- Monitor quarterly compliance with the 3.50:1.00 senior funded debt-to-EBITDA covenant and 1.25:1.00 debt service coverage covenant.
- Confirm the applicable Prime Rate spread and resulting interest expense as borrowings and leverage change.
- Review Exhibit 10.1 for events of default, repayment terms, restrictions, collateral provisions, and other lender remedies.
- Assess the effect of replacing the term loan with the revolving facility on liquidity, leverage, and future financing flexibility.